Literature DB >> 17130620

Tobacco manufacturers' defence against plaintiffs' claims of cancer causation: throwing mud at the wall and hoping some of it will stick.

Sharon Milberger1, Ronald M Davis, Clifford E Douglas, John K Beasley, David Burns, Thomas Houston, Donald Shopland.   

Abstract

BACKGROUND: In the late 1990s and the early part of this decade, the major US cigarette manufacturers admitted, to varying degrees, that smoking causes cancer and other diseases.
OBJECTIVE: To examine how tobacco manufacturers have defended themselves against charges that their products caused cancer in plaintiffs in 34 personal injury lawsuits, all but one of which were litigated between the years 1986 and 2003.
METHODS: Defence opening and closing statements, trial testimony, and depositions for these cases were obtained from the Tobacco Deposition and Trial Testimony Archive (http://tobaccodocuments.org/datta/). All available defence-related transcripts from these cases were reviewed and a content analysis was conducted to identify common themes in the defendants' arguments.
RESULTS: After review of the transcripts, defendants' arguments were grouped into seven categories: (1) there is no scientific proof that cigarette smoking causes lung cancer; (2) the plaintiff did not have lung cancer as claimed; (3) the plaintiff had a type of lung cancer not associated with cigarette smoking; (4) the plaintiff had cancer that may have been associated with cigarette smoking or smokeless tobacco use, but tobacco products were not to blame in this particular case; (5) the plaintiff had cancer that may have been associated with cigarette smoking, but the defendant's cigarette brands were not to blame; (6) the defendant's cigarettes (or smokeless tobacco) may have played a role in the plaintiff's illness/death, but other risk factors were present that negate or mitigate the defendant's responsibility; and (7) the defendant's cigarettes may have been a factor in the plaintiff's illness/death, but the plaintiff knew of the health risks and exercised free will in choosing to smoke and declining to quit. Use of the argument that smoking is not a proven cause of lung cancer declined in frequency during and after the period when tobacco companies began to publicly admit that smoking causes disease. Corresponding increases occurred over time in the use of other arguments (namely, presence of other risk factors and "free will").
CONCLUSIONS: Despite the vast body of literature showing that cigarette smoking causes cancer, and despite tobacco companies' recent admissions that smoking causes cancer, defendants used numerous arguments in these cases to deny that their products had caused cancer in plaintiffs. The cigarette companies, through their public admissions and courtroom arguments, seem to be saying, "Yes, smoking causes lung cancer, but not in people who sue us".

Entities:  

Mesh:

Year:  2006        PMID: 17130620      PMCID: PMC2563590          DOI: 10.1136/tc.2006.016956

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  13 in total

1.  A promise is a promise.

Authors:  K M Cummings
Journal:  Tob Control       Date:  2003-06       Impact factor: 7.552

2.  Epidemiology of bronchioloalveolar carcinoma.

Authors:  R T Falk; L W Pickle; E T Fontham; S D Greenberg; H L Jacobs; P Correa; J F Fraumeni
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1992 Jul-Aug       Impact factor: 4.254

Review 3.  Historians' testimony on "common knowledge" of the risks of tobacco use: a review and analysis of experts testifying on behalf of cigarette manufacturers in civil litigation.

Authors:  Louis M Kyriakoudes
Journal:  Tob Control       Date:  2006-12       Impact factor: 7.552

Review 4.  Transforming the tobacco market: why the supply of cigarettes should be transferred from for-profit corporations to non-profit enterprises with a public health mandate.

Authors:  C Callard; D Thompson; N Collishaw
Journal:  Tob Control       Date:  2005-08       Impact factor: 7.552

Review 5.  The role of tobacco advertising and promotion: themes employed in litigation by tobacco industry witnesses.

Authors:  Marvin E Goldberg; Ronald M Davis; Anne Marie O'Keefe
Journal:  Tob Control       Date:  2006-12       Impact factor: 7.552

Review 6.  The Tobacco Deposition and Trial Testimony Archive (DATTA) project: origins, aims, and methods.

Authors:  Ronald M Davis; Clifford E Douglas; John K Beasley
Journal:  Tob Control       Date:  2006-12       Impact factor: 7.552

7.  Epidemiology of the third wave of tobacco litigation in the United States, 1994-2005.

Authors:  Clifford E Douglas; Ronald M Davis; John K Beasley
Journal:  Tob Control       Date:  2006-12       Impact factor: 7.552

8.  Failed promises of the cigarette industry and its effect on consumer misperceptions about the health risks of smoking.

Authors:  K M Cummings; C P Morley; A Hyland
Journal:  Tob Control       Date:  2002-03       Impact factor: 7.552

Review 9.  Pseudomesotheliomatous adenocarcinoma: a reappraisal.

Authors:  M Koss; W Travis; C Moran; L Hochholzer
Journal:  Semin Diagn Pathol       Date:  1992-05       Impact factor: 3.464

10.  Relation of bronchioloalveolar carcinoma to tobacco.

Authors:  A Morabia; E L Wynder
Journal:  BMJ       Date:  1992-02-29
View more
  10 in total

1.  Philip Morris's website and television commercials use new language to mislead the public into believing it has changed its stance on smoking and disease.

Authors:  Lissy C Friedman
Journal:  Tob Control       Date:  2007-12       Impact factor: 7.552

2.  Tobacco Smoking: Facts and actions.

Authors:  Moeness M Alshishtawy
Journal:  Sultan Qaboos Univ Med J       Date:  2013-06-25

Review 3.  Transnational Tobacco Companies and New Nicotine Delivery Systems.

Authors:  Annalise Mathers; Ben Hawkins; Kelley Lee
Journal:  Am J Public Health       Date:  2018-12-20       Impact factor: 9.308

Review 4.  The role of tobacco advertising and promotion: themes employed in litigation by tobacco industry witnesses.

Authors:  Marvin E Goldberg; Ronald M Davis; Anne Marie O'Keefe
Journal:  Tob Control       Date:  2006-12       Impact factor: 7.552

5.  Don't throw smokeless tobacco users under the bus.

Authors:  Jesse Elias; Yogi Hendlin; Benjamin W Chaffee; Pamela M Ling
Journal:  Addict Behav       Date:  2017-04-10       Impact factor: 3.913

6.  The role of corporate credibility in legitimizing disease promotion.

Authors:  Patricia A McDaniel; Ruth E Malone
Journal:  Am J Public Health       Date:  2008-12-23       Impact factor: 9.308

7.  Cigarettes become a dangerous product: tobacco in the rearview mirror, 1952-1965.

Authors:  Lori Dorfman; Andrew Cheyne; Mark A Gottlieb; Pamela Mejia; Laura Nixon; Lissy C Friedman; Richard A Daynard
Journal:  Am J Public Health       Date:  2013-11-14       Impact factor: 9.308

8.  Testimony by otolaryngologists in defense of tobacco companies 2009-2014.

Authors:  Robert K Jackler
Journal:  Laryngoscope       Date:  2015-07-17       Impact factor: 3.325

9.  Big tobacco focuses on the facts to hide the truth: an algorithmic exploration of courtroom tropes and taboos.

Authors:  Stephan Risi; Robert N Proctor
Journal:  Tob Control       Date:  2019-09-13       Impact factor: 7.552

10.  'Greenwashing' tobacco products through ecological and social/equity labelling: A potential threat to tobacco control.

Authors:  Frank Houghton; Sharon Houghton; Diane O' Doherty; Derek McInerney; Bruce Duncan
Journal:  Tob Prev Cessat       Date:  2018-11-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.